Polymorphisms in the telomerase complex to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials.

Authors

Francesca Battaglin

Francesca Battaglin

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Francesca Battaglin , Fotios Loupakis , Sebastian Stintzing , Shu Cao , Alberto Puccini , Ryuma Tokunaga , Madiha Naseem , Martin D. Berger , Shivani Soni , Jae Ho Lo , Francesca Bergamo , Sara Lonardi , Joshua Millstein , Wu Zhang , Vittorina Zagonel , Chiara Cremolini , Alfredo Falcone , Volker Heinemann , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 566)

DOI

10.1200/JCO.2019.37.4_suppl.566

Abstract #

566

Poster Bd #

G9

Abstract Disclosures